anmelden
Analysen von Michael Leuchten
| 11.08.26 | GSK Buy | Jefferies & Company Inc. | |
| 10.08.26 | Bayer Hold | Jefferies & Company Inc. | |
| 07.08.26 | Sanofi Buy | Jefferies & Company Inc. | |
| 07.08.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 04.08.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 04.08.26 | Bayer Hold | Jefferies & Company Inc. | |
| 03.08.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 30.07.26 | Sanofi Buy | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 28.07.26 | GSK Buy | Jefferies & Company Inc. | |
| 27.07.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 23.07.26 | Novartis Hold | Jefferies & Company Inc. | |
| 22.07.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 21.07.26 | Novartis Hold | Jefferies & Company Inc. | |
| 17.07.26 | GSK Buy | Jefferies & Company Inc. | |
| 13.07.26 | Bayer Hold | Jefferies & Company Inc. | |
| 09.07.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 09.07.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 30.06.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 18.06.26 | Bayer Hold | Jefferies & Company Inc. | |
| 08.06.26 | Roche Underperform | Jefferies & Company Inc. | |
| 04.06.26 | Roche Underperform | Jefferies & Company Inc. | |
| 04.06.26 | GSK Buy | Jefferies & Company Inc. | |
| 29.05.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 29.05.26 | Bayer Hold | Jefferies & Company Inc. | |
| 13.05.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 13.05.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 04.05.26 | Roche Underperform | Jefferies & Company Inc. | |
| 23.04.26 | Roche Underperform | Jefferies & Company Inc. | |
| 23.04.26 | Sanofi Buy | Jefferies & Company Inc. | |
| 20.04.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 15.04.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 10.04.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 31.03.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 26.03.26 | Sanofi Buy | Jefferies & Company Inc. | |
| 27.01.26 | Roche Underperform | Jefferies & Company Inc. | |
| 23.01.26 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 21.01.26 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 24.11.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 10.11.25 | Roche Underperform | Jefferies & Company Inc. | |
| 07.11.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 29.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 28.10.25 | Novartis Hold | Jefferies & Company Inc. | |
| 11.09.23 | AstraZeneca Buy | UBS AG | |
| 05.09.23 | Novo Nordisk Sell | UBS AG | |
| 24.08.23 | Roche Neutral | UBS AG | |
| 21.08.23 | Sartorius vz. Buy | UBS AG | |
| 11.08.23 | Novo Nordisk Sell | UBS AG | |
| 11.08.23 | Bayer Buy | UBS AG | |
| 09.08.23 | Novo Nordisk Sell | UBS AG | |
| 08.08.23 | Bayer Buy | UBS AG | |
